NVLPF (Nova Leap Health) E10: $-0.01 (As of Mar. 2026)


NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.25
GF Value $0.19
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Nova Leap Health E10?

Nova Leap Health NVLPF 50 E10 is $-0.01 as of Mar. 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.19 (Modestly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Nova Leap Health's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.004. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.01 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-25), Nova Leap Health's current stock price is $0.24648. Nova Leap Health's E10 for the quarter that ended in Mar. 2026 was $-0.01. Nova Leap Health's Shiller PE Ratio of today is .


Nova Leap Health  (OTCPK:NVLPF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Nova Leap Health E10 Related Terms


Nova Leap Health E10 Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health E10 Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Nova Leap Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.01

NVLPF vs HCA, THC, DVA: E10 Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's Shiller PE Ratio falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Nova Leap Health's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.004/132.2623*132.2623
=0.004

Current CPI (Mar. 2026) = 132.2623.

Nova Leap Health Quarterly Data

per share eps CPI Adj_EPS
201604 -0.010 101.370 -0.013
201607 -0.010 101.844 -0.013
201610 -0.010 102.002 -0.013
201703 -0.010 102.634 -0.013
201706 -0.010 103.029 -0.013
201709 -0.010 103.345 -0.013
201712 -0.010 103.345 -0.013
201803 -0.010 105.004 -0.013
201806 -0.010 105.557 -0.013
201809 -0.010 105.636 -0.013
201812 0.000 105.399 0.000
201903 -0.010 106.979 -0.012
201906 -0.010 107.690 -0.012
201909 -0.001 107.611 -0.001
201912 -0.010 107.769 -0.012
202003 0.010 107.927 0.012
202006 -0.010 108.401 -0.012
202009 0.007 108.164 0.009
202012 0.020 108.559 0.024
202103 0.013 110.298 0.016
202106 0.005 111.720 0.006
202109 0.015 112.905 0.018
202112 -0.013 113.774 -0.015
202203 -0.005 117.646 -0.006
202206 0.000 120.806 0.000
202209 0.007 120.648 0.008
202212 -0.012 120.964 -0.013
202303 -0.003 122.702 -0.003
202306 -0.002 124.203 -0.002
202309 0.004 125.230 0.004
202312 -0.011 125.072 -0.012
202403 0.005 126.258 0.005
202406 0.003 127.522 0.003
202409 -0.002 127.285 -0.002
202412 0.010 127.364 0.010
202503 -0.001 129.181 -0.001
202506 -0.006 129.892 -0.006
202509 0.005 130.287 0.005
202512 0.000 130.366 0.000
202603 0.004 132.262 0.004

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-0.01 mean?
Nova Leap Health (NVLPF) has a E10 of $-0.01 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Nova Leap Health and its competitors.
Is Nova Leap Health's E10 too high?
Nova Leap Health's current E10 is $-0.01. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's E10 compare to HCA and THC?
Nova Leap Health's E10 of $-0.01 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Nova Leap Health and its competitors. Nova Leap Health's current E10 is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.19, compared to a current price of $0.25 — trading 29.7% above its estimated fair value. The current E10 is $-0.01. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current E10 is $-0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.25 is trading 29.7% above its estimated GF Value™ of $0.19. GuruFocus considers Nova Leap Health to be Modestly Overvalued.

Key valuation signals for NVLPF:

  • E10: $-0.01
  • GF Value™: $0.19 vs. price of $0.25 (29.7% above fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.25
Price
$0.19
GF Value